Reversal of portal hypertension in a patient with primary biliary cirrhosis: Disappearance of esophageal varices and thrombocytopenia

American Journal of Gastroenterology

Volumn 99, Issue 9, 2004, Pages 1859-1860

  El Husseini, Randa ^a   Kaplan, Marshall M ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; METHOTREXATE; PROPRANOLOL; URSODEOXYCHOLIC ACID;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CELL COUNT; CLINICAL FEATURE; ENDOSCOPY; ENZYME ANALYSIS; ESOPHAGUS VARICES; FATIGUE; FEMALE; HUMAN; HUMAN CELL; LABORATORY TEST; LIVER FUNCTION TEST; PORTAL HYPERTENSION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

BIOPSY, NEEDLE; DRUG THERAPY, COMBINATION; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; MIDDLE AGED; PROPRANOLOL; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 4544324557     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.30408.x     Document Type: Article

References (8)

1. Kaplan MM. Primary biliary cirrhosis (review). N Eng J Med 1996;335:1570-8.
2. Gores GJ, Wiesner RH, Dickson ER, et al. Prospective evaluation of esophageal varices in primary biliary. Gastroenterology 1989;96:1552-9.
3. Bonis PAL, Friedman SL, Kaplan MM. Is liver fibrosis reversible? N Engl J Med 2001;344:452-4.
4. Friedman SL. Molecular regulation of hepatic fibrosis: An integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-50.
5. Garcia-Pagan JC, Bosch J, Rodes J. The role of vasoactive mediators in portal hypertension. Semin Gastrointest Dis 1995;6:140-7.
6. Reynaert H, Thompson MG, Thomas A, et al. Hepatic stellate cells: Role in microcirculation and pathophysiology of portal hypertension. Gut 2002;50:571-81.
7. Bathal PS, Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol 1985;1:325-9.
8. Lindor Kd, Jorgenson RA, Therneau TM, et al. Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis. Mayo Clin Proc 1997;72:1137-40.